Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use.

Eur Respir J

Otsuka Pharmaceutical Development and Commercialization Inc., Rockville, MD, USA.

Published: July 2017

http://ow.ly/tA6Y30cs2Yg

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898945PMC
http://dx.doi.org/10.1183/13993003.00311-2017DOI Listing

Publication Analysis

Top Keywords

early outcomes
4
outcomes mdr-tb
4
mdr-tb xdr-tb
4
xdr-tb patients
4
patients treated
4
treated delamanid
4
delamanid compassionate
4
compassionate http//owly/ta6y30cs2yg
4
early
1
mdr-tb
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!